Emilio Rodrigo, Luis F Quintana, Teresa Vázquez-Sánchez, Ana Sánchez-Fructuoso, Anna Buxeda, Eva Gavela, Juan M Cazorla, Sheila Cabello, Isabel Beneyto, María O López-Oliva, Fritz Diekmann, José M Gómez-Ortega, Natividad Calvo Romero, María J Pérez-Sáez, Asunción Sancho, Auxiliadora Mazuecos, Jordi Espí-Reig, Carlos Jiménez, Domingo Hernández
BACKGROUND: Immunoglobulin A nephropathy (IgAN) is the most frequent recurrent disease in kidney transplant recipients and its recurrence contributes to reducing graft survival. Several variables at the time of recurrence have been associated with a higher risk of graft loss. The presence of clinical or subclinical inflammation has been associated with a higher risk of kidney graft loss, but it is not precisely known how it influences the outcome of patients with recurrent IgAN. METHODS: We performed a multicentre retrospective study including kidney transplant recipients with biopsy-proven recurrence of IgAN in which Banff and Oxford classification scores were available...
January 2024: Clinical Kidney Journal